B
Bausch Health Companies Inc. (BHC)
NYQ – Real Time Price. Currency in USD
5.02
-0.10 (-1.95%)
At close: Mar 27, 2026, 4:00 PM EDT
5.00
-0.02 (-0.40%)
After-hours: Mar 27, 2026, 6:28 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
5.02
-0.10 (-1.95%)
At close: Mar 27, 2026, 4:00 PM EDT
5.00
-0.02 (-0.40%)
After-hours: Mar 27, 2026, 6:28 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.47 | 2.52 | 7.0 | |
| Quick ratio | 1.08 | 1.78 | 7.0 | |
| Debt to Equity | N/A | -0.80 | 1.0 | |
| Debt to Assets | 0.80 | 0.73 | 2.0 | |
| Interest coverage | 1.80 | -13.90 | 5.0 | |
| Weighted average score | 4.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 7.80B | 8.92B | 9.16B | 10.45B | 10.32B |
| Gross Profit | 4.36B | 5.21B | 5.49B | 6.36B | 6.28B |
| Operating Income | 1.34B | 1.63B | 1.76B | 2.22B | 2.19B |
| Net Income | -216M | -603M | -44M | 160M | 156M |
| EBITDA | 2.67B | 2.92B | 2.97B | 3.45B | 3.41B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 10.72 | 15.75 | 8.0 |
| Next quarter | 2.65 | -4.61 | 2.5 |
| Current year | 4.04 | 13.8 | 6.0 |
| Next year | 0.21 | -5.91 | 1.5 |
| Weighted average score | 4.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 7.09 | -164.24 | -7.73 | 29.31 | 4.3 |
| Y/Y | 14.16 | -225.82 | -4.75 | -15.81 | 2.8 |
| 3y average | 10.35 | 126.18 | 4.7 | 71.08 | 7.8 |
| 5y average | 4.66 | 79.24 | 0.59 | 12 | 5.8 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $21.0B significantly exceeds cash reserves ($1.3B), raising financial stability concerns
Total current assets $6.1B exceed Total current liabilities $4.2B, highlighting excellent liquidity
Debt-to-equity ratio (55.9) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (2x) is sufficient but not particularly strong
The company generates positive free cash flow $402.5M, supporting its financial health